Marcel Schmidt

Marcel Schmidt

Auto-generated profile, based on publicly available information

Marcel Schmidt

Van ‘t Hoff Institute for Molecular Sciences (HIMS) Science Park 904 1098 XH Amsterdam The Netherlands

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
MSMarcel Schmidt
Marcel Schmidt
ATAna Toplak
Ana Toplak
PQPeter Jlm Quaedflieg
Peter Jlm Quaedflieg
TNTimo Nuijens
Timo Nuijens

8 May 2017 in Advanced Synthesis & Catalysis
Verified
Journal Article
Closed access
PDF file
MSMarcel Schmidt
Marcel Schmidt
ATAna Toplak
Ana Toplak
PQPeter J. L. M. Quaedflieg
Peter J. L. M. Quaedflieg
HIHans Ippel
Hans Ippel
GRGaston J. J. Richelle
Gaston J. J. Richelle
TNTimo Nuijens
Timo Nuijens

7 November 2019 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
JPJan Pawlas
Jan Pawlas
TNTimo Nuijens
Timo Nuijens
JPJonas Persson
Jonas Persson
TSThomas Svensson
Thomas Svensson
MSMarcel Schmidt
Marcel Schmidt
JRJon H. Rasmussen
Jon H. Rasmussen
Using a large scale biocatalytic manufacture of the antidiabetic exenatide as an example, we report that chemo-enzymatic peptide synthesis (CEPS) constitutes an efficient method for sustainable manufacturing of therapeutic peptides. The H-22-39-NH2 and H-1-21-O-Cam-L-NH2 exenatide fragments requisite for the enzymatic ligations were synthesized by solid-phase peptide synthesis (SPPS) methods and in ligations of these fragments catalyzed by omniligase-1, a broad specificity ligase engineered from subtilisin BPN’, we found that at pH 9.1/37 °C a substantial formation of deamidation impurities occurs. Consequently, a more robust ligation protocol (pH 7.5, rt, 10% MeCN as co-solvent) was developed and used in efficient scale-up ligations of the two fragments both as crude peptides as well as in their purified forms. Further, the aromatic 4-hydroxymethylbenzoic acid (HMBA) was evaluated as a more robust alternative for the carboxamidomethyl (O-Cam linker), which exhibited limited stability during some steps of the elevated temperature (ET) SPPS of the H-1-21-O-Cam-L-NH2 fragment. An SPPS process to obtain H-1-21-HMBA-K fragment in good yield and purity was developed and this peptide was used with the H-22-39-NH2 fragment in a large scale omniligase-1 catalyzed ligation affording 53 g of crude exenatide with excellent yield and high turnover numbers (TON). The crude product was purified to obtain exenatide API, demonstrating that CEPS can be used for large scale manufacturing of therapeutic peptides in economically as well as environmentally sustainable manner. Cost of manufacturing, complete E factor (cEF) and Carbon Intensity (CI) were determined for all process routes herein vs. a conventional and a lab scale CEPS benchmark processes. This revealed that the CEPS exenatide processes which employed the H-1-21-HMBA-K fragment were not only successfully scaled but also improved in terms of economy as well as environmental footprint compared to both benchmark process routes.

1 December 2017 in Drug Discovery Today: Technologies
Verified
Journal Article
Closed access
MSMarcel Schmidt
Marcel Schmidt
ATAna Toplak
Ana Toplak
PQPeter J.L.M. Quaedflieg
Peter J.L.M. Quaedflieg
JMJan H. van Maarseveen
Jan H. van Maarseveen
TNTimo Nuijens
Timo Nuijens

4 January 2018 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
MSMarcel Schmidt
Marcel Schmidt
ATAna Toplak
Ana Toplak
HRHenriëtte J. Rozeboom
Henriëtte J. Rozeboom
HWHein J. Wijma
Hein J. Wijma
PQPeter J. L. M. Quaedflieg
Peter J. L. M. Quaedflieg
TNTimo Nuijens
Timo Nuijens
A substrate-tailored peptide ligase for the chemo-enzymatic peptide synthesis (CEPS) of thymosin-α1.

26 March 2019 in Organic Letters
Verified
Journal Article
Open access
DSDieuwertje E. Streefkerk
Dieuwertje E. Streefkerk
MSMarcel Schmidt
Marcel Schmidt
JIJohannes H. Ippel
Johannes H. Ippel
THTilman M. Hackeng
Tilman M. Hackeng
TNTimo Nuijens
Timo Nuijens
JMJan H. van Maarseveen
Jan H. van Maarseveen
In Nature, multicyclic peptides constitute a versatile molecule class with various biological functions. For their pharmaceutical exploitation, chemical methodologies that enable selective consecutive macrocyclizations are required. We disclose a combination of enzymatic macrocyclization, CLIPS alkylation, and oxime ligation to prepare tetracyclic peptides. Five new small molecular scaffolds and differently sized model peptides featuring noncanonical amino acids were synthesized. Enzymatic macrocyclization, followed by one-pot scaffold-assisted cyclizations, yielded 21 tetracyclic peptides in a facile and robust manner.